Using ketamine in treatment resistant depress...

Prof. Klaus Ebmeier is the Foundation Chair of Old Age Psychiatry. In this interview he gives his point of view on dementia, normal aging and why new treatments are not yet effective. He also explains why failure is the bread-and-butter of research and gives valuable advice to fu ...  Show more

An interview with Professor Phil Burnet, who discusses his research into the influence of the gut microbiome on brain health. He talks about novel findings, potential future work, and takes questions from trainee psychiatrists and researchers. 

Dr. John Krystal, a leading psychiatrist and neuroscientist, explains how ketamine works in the brain, why it’s revolutionizing depression treatment, and what the future holds for psychedelic-assisted therapy. His journey to discovering the revolutionary benefits of Ketamine trea ...  Show more

Dr. Mike Dow is healing severe mental disorders with ketamine. The certified psychedelic ketamine-assisted psychotherapist advocates for the drug that is more effective than standard antidepressants. Today, Dr. Dow shares the history of ketamine and how it has been developed to h ...  Show more

Dr. Rebecca Price (University of Pittsburgh) discusses a novel, computer-based intervention designed to extend the antidepressant effects of a single dose of ketamine. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the December issue and what draws it togethe ...  Show more

New developments in actor Matthew Perry’s death are shining a light on the ethics and efficacy of using ketamine as a therapeutic drug. To learn more about the promise and pitfalls of ketamine treatment, CNN’s Chief Medical Correspondent Dr. Sanjay Gupta turns to David Feifel, on ...  Show more